Medicare recipients are facing unprecedented increases in their prescription drug costs, with some medications nearly ...

Americans pay significantly more for prescription medications, with branded drugs in the U.S. costing about three times more ...

A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often ...

Trump's plan to lower Medicare drug costs by aligning U.S. prices with other countries faces legal and industry challenges.

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

There are expenses that Medicare won't cover in 2025, and it's important to find other ways to cover these costs.

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

UnitedHealth Group will stop compensative brokers and sales agents who sell new Medicare Part D prescription drug plans.

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

President Donald Trump signed a sweeping executive order Monday morning that promises to crack down on “unreasonable or ...

President Trump signed an executive order Monday that will attempt to bring the down the cost of some drugs in the United ...

President Donald Trump has signed a sweeping executive order setting a 30-day deadline for drugmakers to lower the cost of ...